Carcinogenic Effects of "Whole-Life" exposure to inorganic arsenic in CD1 mice

Toxicological Sciences

Volumn 119, Issue 1, 2011, Pages 73-83

  Tokar, Erik J ^a   Diwan, Bhalchandra A ^b   Ward, Jerrold M ^c   Delker, Don A ^d   Waalkes, Michael P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b SAIC FREDERICK INC   (United States)

^c Global VetPathology   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Carcinogenesis; Mice; Whole life exposure

Indexed keywords

ARSENIC; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR ALPHA;

ADRENAL TUMOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; FEMALE; GALLBLADDER TUMOR; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; MALE; MOUSE; NONHUMAN; OCCUPATIONAL EXPOSURE; OVARY TUMOR; PROTEIN EXPRESSION; SKIN CANCER; UTERUS CARCINOMA;

MUS;

EID: 78650607855     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq315     Document Type: Article

References (54)

1. Anderson, L. M., Diwan, B. A., Fear, N. T., and Roman, E. (2000). Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ. Health Perspect. 108, 573-594.
2. Arnold, L. L., Eldan, M., Nyska, A., van Gemert, M., and Cohen, S. M. (2006). Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice. Toxicology 223, 82-100.
3. Barker, D. J. P. (2007). The origins of the developmental origins theory. J. Intern. Med. 261, 412-417.
4. Bertolini, G., Roz, L., Perego, P., Tortoreto, M., Fontanella, E., Gatti, L., Pratesi, G., Fabbri, A., Andriani, F., Tinelli, S., et al. (2009). Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc. Natl. Acad. Sci. U.S.A. 106, 16281-16286.
5. Birnbaum, L. S., and Fenton, S. E. (2003). Cancer and developmental exposure to endocrine disruptors. Environ. Health Perspect. 111, 389-394.
6. Bomken, S., Fiser, K., Heidenreich, O., and Vormoor, J. (2010). Understanding the cancer stem cell. Br. J. Cancer 103, 439-445.
7. Byron, W. R., Bierbower, G. W., Brouwer, J. B., and Hansen, W. H. (1967). Pathologic changes in rats and dogs from two-year feeding of sodium arsenite or sodium arsenate. Toxicol. Appl. Pharmacol. 10, 132-147.
8. Cao, Y., and Karin, M. (2003). NF-kappaB in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8, 214-223.
9. Chen, Z., Chen, G. Q., Shen, Z. X., Sun, G. L., Tong, J. H., Wang, Z. Y., and Chen, S. J. (2002). Expanding the use of arsenic trioxide: leukemias and beyond. Semin. Hematol. 39, 22-26.
10. Coppin, J., Qu, W., and Waalkes, M. P. (2008). Interplay between cellular methyl metabolism and adaptive efflux during oncogenic transformation from chronic arsenic exposure in human cells. J. Biol. Chem. 283, 19342-19350.
11. Cui, X., Wakai, T., Shirai, Y., Hatakeyama, K., and Hirano, S. (2006). Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol. Sci. 91, 372-381.
12. De Bosscher, K., Venden Berghe, W., and Haegeman, G. (2006). Cross-talk between nuclear receptors and nuclear factor kB. Oncogene 25, 6868-6886.
13. Frasor, J., Weaver, A., Pradham, M., Dai, Y., Miller, L. D., Lin, C.-Y., and Stanculescu, A. (2009). Positive cross-talk between estrogen receptor and NH-kB in breast cancer. Cancer Res. 69, 8918-8925.
14. Huff, J., Jacobson, M. F., and Davis, D. L. (2008). The limits of two-year bioassay exposure regimens for identifying chemical carcinogens. Environ. Health Perspect. 116, 1439-1442.
15. Institute of Laboratory Animal Resources (ILAR). (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
16. International Agency for Research on Cancer (IARC). (1973). International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Some Inorganic and Organometallic Compounds, Arsenic and Inorganic Arsenic Compounds, Vol. 2, pp. 48-73. IARC Press, Lyon, France.
17. International Agency for Research on Cancer (IARC). (1980). International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Some Metals and Metallic Compounds, Arsenic and Arsenic Compounds, Vol. 23, pp. 39-143. IARC Press, Lyon, France.
18. International Agency for Research on Cancer (IARC). (1987). International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs. Arsenic and Arsenic Compounds, Vol. 1-42, pp. 100-106. IARC Press, Lyon, France.
19. International Agency for Research on Cancer (IARC). (2004). Arsenic in Drinking Water. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risk to Humans. Some Drinking Water Disinfectants and Contaminants, Including Arsenic, Vol. 84, pp. 269-477. IARC Press, Lyon, France.
20. International Agency for Research on Cancer (IARC). (2009). IARC Special Report: Policy, A review of Human Carcinogens-Part C: Metals, Arsenic, Dusts, and Fibres, Vol. 10, pp. 453-454. IARC Press, Lyon, France.
21. Kangsamaksin, T., Park, H. J., Trempus, C. S., and Morris, R. J. (2007). A perspective on murine keratinocyte stem cells as targets of chemically induced skin cancer. Mol. Carcinog. 46, 579-584.
22. Kanisawa, M., and Schroeder, H. A. (1967). Life term studies on the effects of arsenic, germanium, tin, and vanadium on spontaneous tumors in mice. Cancer Res. 27, 1192-1195.
23. Kanisawa, M., and Schroeder, H. A. (1969). Life term studies on the effect of trace elements on spontaneous tumors in mice and rats. Cancer Res. 29, 892-895.
24. Kim, J., Lee, J. J., Kim, J., Gardner, D., and Beachy, P. A. (2010). Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc. Natl. Acad. Sci. U.S.A. 107, 13432-13437.
25. Kobayashi, Y., and Hirano, S. (2008). Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile. Toxicol. Appl. Pharmacol. 232, 33-40.
26. Liaw, J., Marshall, G., Yuan, Y., Ferreccio, C., Steinmaus, C., and Smith, A. H. (2008). Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol. Biomarkers Prev. 17, 1982-1987.
27. Ma, S., Chan, K. W., Lee, T. K., Tang, K. H., Wo, J. Y., Zheng, B. J., and Guan, X. Y. (2008). Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol. Cancer Res. 6, 1146-1153.
28. National Science Foundation (NSF). (2005). Committee on How Toxicogenomics Could Inform Critical Issues in Carcinogenic Risk Assessment of Environmental Chemicals. In Toxicogenomic technologies and risk assessment of environmental carcinogens: A workshop study, pp. 1-55. National Academies Press, Washington, DC.
29. Nelson, G. M., Ahlborn, G. J., Allen, J. W., Ren, H., Corton, J. C., Waalkes, M. P., Kitchin, K. T., Diwan, B. A., Knapp, G., and Delker, D. A. (2009). Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic. Toxicology 266, 6-15.
30. Ouyang, W., Zhang, D., Ma, Q., Li, J., and Huang, C. (2007). Cyclooxygenase2 induction by arsenite through the IKKbeta/NkkappaB pathway exerts an antiapoptotic effect in mouse epidermal C141 cells. Environ. Health Perspect. 115, 513-518.
31. Patterson, T. J., Reznikova, T. V., Phillips, M. A., and Rice, R. H. (2005). Arsenite maintains germinative state in cultured human epidermal cells. Toxicol. Appl. Pharmacol. 207, 69-77.
32. Patterson, T. J., and Rice, R. H. (2007). Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential. Toxicol. Appl. Pharmacol. 221, 119-128.
33. Pedram, A., Razandi, M., Aitkenhead, M., Hughes, C. C. W., and Levin, E. R. (2002). Integration of the non-genomic and genomic actions of estrogen; membrane-initiated signaling by steroid to transcription and cell biology. J. Biol. Chem. 277, 50768-50775.
34. Rice, J. M., Diwan, B. A., Donovan, P. J., and Perantoni, A. O. (1987). In Mechanisms of Transplacental Carcinogenesis: Mutation, Oncogene Activation, and Tumor Suppression. Banbury Report 26: Developmental Toxicology: Mechanisms and Risk, pp. 137-151. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
35. Rountree, C. B., Ding, W., He, L., and Stiles, B. (2009). Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells 27, 290-299.
36. Seth, P., Krop, I., Porter, D., and Polyak, K. (2002). Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Oncogene 21, 836-843.
37. Smith, A. H., Marshall, G., Yuan, Y., Ferreccio, C., Liaw, J., von Ehrenstein, O., Steinmaus, C., Bates, M. N., and Selvin, S. (2006). Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114, 1293-1296.
38. Soignet, S. L., Maslak, P., Wang, Z.-G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., et al. (1998). Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339, 1341-1348.
39. Sullivan, J. P., Minna, J. D., and Shay, J. W. (2010). Evidence for selfrenewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev. 29, 61-72.
40. Tokar, E. J., Diwan, B. A., and Waalkes, M. P. (2010a). Arsenic exposure in utero and non-epidermal proliferative response in adulthood in Tg. AC mice. Int. J. Toxicol. 29, 291-296.
41. Tokar, E. J., Diwan, B. A., and Waalkes, M. P. (2010b). Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environ. Health Perspect. 118, 108-115.
42. Tokar, E. J., Qu, W., Liu, J., Liu, W., Webber, M. M., Phang, J. M., and Waalkes, M. P. (2010c). Arsenic-specific stem cell selection during malignant transformation. J. Natl. Cancer Inst. 102, 638-649.
43. Waalkes, M. P., Liu, J., Chen, H., Xie, Y., Achanzar, W. E., Zhou, Y.-S., Cheng, M.-L., and Diwan, B. A. (2004a). Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J. Natl. Cancer Inst. 96, 466-474.
44. Waalkes, M. P., Liu, J., and Diwan, B. A. (2007). Transplacental arsenic carcinogenesis in mice. Toxicol. Appl. Pharmacol. 222, 271-280.
45. Waalkes, M. P., Liu, J., Germolec, D. R., Trempus, C. S., Cannon, R. E., Tokar, E. J., Tennant, R. W., Ward, J. M., and Diwan, D. A. (2008). Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res. 68, 8278-8285.
46. Waalkes, M. P., Liu, J., Ward, J. M., and Diwan, D. A. (2006a). Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicol. Appl. Pharmacol. 215, 295-305.
47. Waalkes, M. P., Liu, J., Ward, J. M., Powell, D. A., and Diwan, B. A. (2006b). Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res. 66, 1337-1345.
48. Waalkes, M. P., Ward, J. M., and Diwan, B. A. (2004b). Induction of tumors of the liver, lung, ovary, and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25, 133-141.
49. Waalkes, M. P., Ward, J. M., Liu, J., and Diwan, B. A. (2003). Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186, 7-17.
50. Wicha, M. S., Liu, S., and Dontu, G. (2006). Cancer stem cells: an old idea-a paradigm shift. Cancer Res. 66, 1883-1890.
51. Wistuba, I. I., and Gazdar, A. F. (2004). Gallbladder cancer: lessons from a rare tumour. Nat. Rev. Cancer 4, 695-706.
52. Yang, C., Chen, L., Li, C., Lynch, M. C., Brisken, C., and Schmidt, E. V. (2010). Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. Mol. Cell Biol. 30, 3111-3125.
53. Yuan, Y., Marshall, G., Ferreccio, C., Steinmaus, C., Liaw, J., Bates, M., and Smith, A. H. (2010). Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology 21, 103-108.
54. Zhou, Y., Eppenberer-Castori, S., Eppenberger, U., and Benz, C. C. (2005). The NFκB pathway and endocrine-resistant breast cancer. Endocr. Relat. Cancer 12, S37-S46.